BE854270A - ANTI-TUMOR MEDICINAL PRODUCT BASED ON LYSOLECITHIN-TYPE COMPOUND - Google Patents

ANTI-TUMOR MEDICINAL PRODUCT BASED ON LYSOLECITHIN-TYPE COMPOUND

Info

Publication number
BE854270A
BE854270A BE177280A BE177280A BE854270A BE 854270 A BE854270 A BE 854270A BE 177280 A BE177280 A BE 177280A BE 177280 A BE177280 A BE 177280A BE 854270 A BE854270 A BE 854270A
Authority
BE
Belgium
Prior art keywords
lysolecithin
type compound
product based
medicinal product
tumor medicinal
Prior art date
Application number
BE177280A
Other languages
French (fr)
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of BE854270A publication Critical patent/BE854270A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BE177280A 1976-05-04 1977-05-04 ANTI-TUMOR MEDICINAL PRODUCT BASED ON LYSOLECITHIN-TYPE COMPOUND BE854270A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2619686A DE2619686C2 (en) 1976-05-04 1976-05-04 Use of a lysolecithin for tumor treatment

Publications (1)

Publication Number Publication Date
BE854270A true BE854270A (en) 1977-11-04

Family

ID=5977045

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177280A BE854270A (en) 1976-05-04 1977-05-04 ANTI-TUMOR MEDICINAL PRODUCT BASED ON LYSOLECITHIN-TYPE COMPOUND

Country Status (15)

Country Link
JP (1) JPS52134027A (en)
AU (1) AU517586B2 (en)
BE (1) BE854270A (en)
CA (1) CA1094455A (en)
DE (1) DE2619686C2 (en)
FR (1) FR2364656A1 (en)
GB (1) GB1583661A (en)
IE (1) IE44927B1 (en)
IL (1) IL51988A (en)
IT (1) IT1071329B (en)
LU (1) LU77248A1 (en)
NL (1) NL189672C (en)
NZ (1) NZ183981A (en)
SE (1) SE7705071L (en)
ZA (1) ZA772649B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5396311A (en) * 1977-01-29 1978-08-23 Toyama Chem Co Ltd Anti-cander drugs containing lysolecithins
JPS5528955A (en) * 1978-08-24 1980-02-29 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.
GB2046092B (en) 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS5772914A (en) 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
DE3265157D1 (en) * 1981-03-30 1985-09-12 Takeda Chemical Industries Ltd Ethyleneglycol derivatives, their production and use
DE3127503A1 (en) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim NEW PHOSPHOLIPIDS, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3131524A1 (en) * 1981-08-08 1983-02-24 Röhm GmbH, 6100 Darmstadt METHOD FOR PRODUCING PHYSIOLOGICAL EFFECTORS
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
DE3239858A1 (en) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen NEW D-MANNITE DERIVATIVES AS STARTING PRODUCTS FOR THE SYNTHESIS OF PHOSPHOLIPIDES
DE3239817A1 (en) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen NEW GLYCER DERIVATIVES FOR THE SYNTHESIS OF PHOSPHOLIPIDES
EP0103877B1 (en) * 1982-09-21 1987-01-07 Fujisawa Pharmaceutical Co., Ltd. Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
ATE41007T1 (en) * 1985-07-15 1989-03-15 Takeda Chemical Industries Ltd 2-ALKANOYLOXYPROPANDERIVATES, THEIR PREPARATION AND USE.
JPS6294A (en) * 1986-05-09 1987-01-06 Toyama Chem Co Ltd Novel glycerophosphoric acid derivative and salt and production thereof
JP2561478B2 (en) * 1986-07-22 1996-12-11 武田薬品工業株式会社 Glycerin derivative
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (en) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3- (C (DOWN ARROW)) (DOWN ARROW) (DOWN ARROW) 6 (DOWN ARROW) -C (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) 8 (DOWN ARROW)) ALKANSULFINYL AND 2 SULPHONE -METHOXYMETHYL-PROPYL) - (2-TRIMETHYLAMMONIO-ETHYL) PHOSPHATES, METHOD FOR PRODUCING THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3918082A1 (en) * 1989-06-02 1991-01-24 Max Planck Gesellschaft AGENT FOR AUTOIMMUNE DISEASES
DE3935580C2 (en) * 1989-10-25 1998-05-28 Medmark Pharma Gmbh Use of an active pharmaceutical ingredient for the treatment of HIV infections
EP0581793A1 (en) * 1991-04-25 1994-02-09 University Of British Columbia Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents
ES2034885B1 (en) * 1991-07-10 1994-03-01 Menarini Lab PROCEDURE FOR THE PREPARATION OF CETOALQUILGLICEROFOSFOLIPIDOS.
ATE198419T1 (en) * 1994-10-14 2001-01-15 Liposome Co Inc ETHERLIPID LIPOSOMES AND THEIR THERAPEUTIC USE
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5965159A (en) * 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US6135426A (en) * 1998-01-07 2000-10-24 Briggs And Stratton Corporation Priming system for internal combustion engines
CN101610758A (en) 2006-11-10 2009-12-23 阿尔法普托斯有限公司 The peroral dosage form that contains tri-substituted glycerol compounds
US8324188B2 (en) 2006-11-10 2012-12-04 Vladimir Khazak Combinations of ET-18-O-CH3and anti-cancer agents for the treatment of cancer
ES2391226T3 (en) * 2006-12-20 2012-11-22 Alphaptose Gmbh Topical pharmaceutical form comprising tri-substituted glycerol compounds
RU2474427C2 (en) * 2006-12-20 2013-02-10 Универзитетсклиникум Хамбург-Эппендорф Use of tri-substituted glycerol compounds for treating hematological malignant tumours
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009341C3 (en) * 1970-02-27 1979-06-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen 3-Octadecyloxy-propanol- (l) -phosphoric acid monocholine ester and process for its preparation
DE2009342C3 (en) * 1970-02-27 1980-12-18 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Use of glycerol alkyl ether (l) phosphoric acid (3) monocholine esters
DE2009343C3 (en) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Use of lysolecithins as immunological adjuvants
DE2033361C3 (en) * 1970-07-06 1980-02-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Acylpropanediol- (13) -phosphoric acid choline ester and process for their preparation

Also Published As

Publication number Publication date
IL51988A (en) 1981-05-20
LU77248A1 (en) 1977-12-13
ZA772649B (en) 1978-04-26
NL189672B (en) 1993-01-18
FR2364656B1 (en) 1980-03-07
FR2364656A1 (en) 1978-04-14
NL189672C (en) 1993-06-16
AU2481977A (en) 1978-11-09
DE2619686A1 (en) 1977-11-24
SE7705071L (en) 1977-11-05
CA1094455A (en) 1981-01-27
AU517586B2 (en) 1981-08-13
IL51988A0 (en) 1977-07-31
JPS52134027A (en) 1977-11-09
IT1071329B (en) 1985-04-02
NZ183981A (en) 1980-04-28
NL7704723A (en) 1977-11-08
IE44927B1 (en) 1982-05-19
DE2619686C2 (en) 1986-08-07
IE44927L (en) 1977-11-04
GB1583661A (en) 1981-01-28
JPS6146455B2 (en) 1986-10-14

Similar Documents

Publication Publication Date Title
BE854270A (en) ANTI-TUMOR MEDICINAL PRODUCT BASED ON LYSOLECITHIN-TYPE COMPOUND
FR2304348A1 (en) ZINCIC SULFADIAZINE MEDICINAL PRODUCT
BE838938A (en) EFFERVERSCENT SWEETENER TABLETS
SE7709359L (en) PHARMACEUTICAL DOSAGE FORM
BE854925A (en) 12-AZAPROSTANOIC ACIDS USEFUL AS A MEDICINAL PRODUCT
BE883495A (en) HYPOLIPEMIC MEDICINAL PRODUCT BASED ON CARNITINE
BE844532A (en) MEDICINAL PRODUCT BASED ON A BENZOTHIADIAZOLE DERIVATIVE
FR2307541A1 (en) MEDICINAL PRODUCT BASED ON A POLYPEPTIDE
FI763506A (en) PHARMACEUTICAL NAERINGSFOERPACKNING
BE862872A (en) MEDICINAL PRODUCT BASED ON A CONDENSE BICYCLIC HETEROCYCLIC COMPOUND
FI773812A (en) PHARMACEUTICAL FORM
JPS52128357A (en) Antiitumor drug
SE7705851L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION
JPS5296750A (en) Oral drug compound
FI773813A (en) PHARMACEUTICAL FORM
JPS5325579A (en) Pharmaceutical compound
BE853569A (en) MEDICINAL PREPARATIONS
FR2342067A1 (en) MEDICINE BASED ON A DERIVATIVE OF QUINOLEINE
FR2347043A1 (en) DIURETIC DRUG
BE811547A (en) DRUG BASED ON A DERIVATIVE OF 7H-BENZOCYCLOHEPTENE-7-ONE
FR2337555A1 (en) DRUG BASED ON 1,3-BIS (2-TETRAHYDROFURYL) -5-FLUORO-URACIL
AU517608B2 (en) Medicaments
BE801014A (en) MEDICINAL PRODUCT BASED ON (HYDROXY-2 INDANYL-2) 1 PROPYLAMINE
JPS5338620A (en) Isomalin antiimold drug
ZA777335B (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENS

Effective date: 19970504